DRUG · Unmapped registry intervention
Metformin on top of intensive insulin therapy
Find medicine records ·
Find other trials using this name
Clinical trial
The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled Trial
NCT00375388
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedThe HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled Trial
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Sponsors & collaborators
Bethesda General Hospital, Hoogeveenlead sponsor
Takedacollaborator
LifeScancollaborator
Merck KGaA, Darmstadt, Germanycollaborator
Dupont Merckcollaborator
Merck Sharp & Dohme LLCcollaborator
Novo Nordisk A/Scollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00375388 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.